Back
BioCryst Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$7.70
Seasonality Move:
3.63%
7 Day Trial
ALL ACCESS PASS
$
7
BioCryst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 51% based on the past 31 years of stock performance.
-
BioCryst Pharmaceuticals, Inc. has risen higher in 13 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.94%
-
Is BioCryst Pharmaceuticals, Inc. Stock Undervalued?The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $7.70. The Score for BCRX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
BCRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioCryst Pharmaceuticals, Inc. has on average historically risen by 51% based on the past 31 years of stock performance.
BioCryst Pharmaceuticals, Inc. Stock Rating
Buy
66
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. overpriced?
-
BioCryst Pharmaceuticals, Inc. has risen higher in 13 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.94%
BioCryst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
11.31
52-Week Low:
6.00
Prediction Charts
Market Cap:
1.6B
Price in USD:
7.70
Volume:
1.5M
Beta:
1.66
Technical Analysis
SMA50:
7.19
SMA100:
7.59
SMA200:
8.25
52-Wk Change:
0.39%
Stock Predictions
-
Is BioCryst Pharmaceuticals, Inc. stock public?Yes, BioCryst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the BioCryst Pharmaceuticals, Inc. stock quote today?The BioCryst Pharmaceuticals, Inc. stock price is 7.70 USD today.
-
How to buy BioCryst Pharmaceuticals, Inc. stock online?You can buy BioCryst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 7.85 | 7.83 | 8.17 | 7.79 |
| Dec-5 | 7.84 | 7.59 | 7.93 | 7.45 |
| Dec-8 | 7.71 | 7.70 | 7.98 | 7.66 |
| Dec-9 | 7.70 | 7.64 | 7.85 | 7.63 |
| Dec-10 | 7.62 | 7.66 | 7.69 | 7.51 |
| Dec-11 | 7.68 | 7.58 | 7.77 | 7.54 |
| Dec-12 | 7.82 | 7.57 | 7.82 | 7.23 |
| Dec-15 | 7.64 | 7.59 | 7.92 | 7.44 |
| Dec-16 | 7.61 | 7.47 | 7.70 | 7.36 |
| Dec-17 | 7.44 | 7.13 | 7.58 | 7.11 |
| Dec-18 | 7.19 | 7.29 | 7.38 | 7.12 |
| Dec-19 | 7.24 | 7.41 | 7.56 | 7.19 |
| Dec-22 | 7.40 | 7.61 | 7.69 | 7.35 |
| Dec-24 | 7.48 | 7.70 | 7.76 | 7.47 |
BioCryst Pharmaceuticals, Inc. Earnings
BioCryst Pharmaceuticals, Inc. Earnings Report: Per Share BioCryst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals, Inc. Forecast Revenue Growth
BioCryst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.05 per share.
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.